Nosebleeds: When to See a Doctor and What Causes Them

Why Nosebleeds Happen: The Anatomy Behind Epistaxis

A nosebleed starts because blood vessels inside the nose rupture. The nasal cavity contains a dense vascular network, and the area most vulnerable to bleeding sits on the anterior nasal septum in a region called Kiesselbach's plexus (also called Little's area). This spot is where branches of the anterior ethmoidal, sphenopalatine, superior labial, and greater palatine arteries converge into a superficial web of capillaries covered by thin mucosa [1].

Because these vessels lie so close to the surface, even minor insults can trigger a bleed. A 2008 systematic review in the Journal of Laryngology & Otology estimated that roughly 60% of people will experience at least one episode of epistaxis during their lifetime, though only about 6% seek medical attention [2]. Children between ages 2 and 10 and adults over 50 are the two peak-incidence groups. The pediatric peak is driven largely by nose picking and upper respiratory infections. The adult peak is driven by anticoagulant use, hypertension, and mucosal atrophy.

Posterior nosebleeds originate deeper in the nasal cavity, typically from branches of the sphenopalatine artery. They are less common but far more dangerous. A retrospective analysis published in Rhinology found that posterior bleeds accounted for 5% to 10% of ED epistaxis presentations but were responsible for a disproportionate share of hospital admissions [3]. Blood may flow down the throat rather than out of the nostrils, which makes them harder to detect and control.

Common Causes of Nosebleeds

Dry air and mechanical irritation are the two most frequent triggers. Heating systems that reduce indoor humidity below 30% desiccate the nasal mucosa, creating small cracks that bleed. Nose picking remains the single most common cause in children [4].

Beyond those triggers, the list of recognized causes includes:

• Medications. Anticoagulants (warfarin, apixaban, rivarelbaban) and antiplatelet agents (aspirin, clopidogrel) increase both the frequency and duration of nosebleeds. A 2018 cohort study in Thrombosis Research found that patients on direct oral anticoagulants had a 2.3-fold higher rate of epistaxis compared to matched controls not on anticoagulation [5].
• Topical nasal sprays. Intranasal corticosteroids like fluticasone and mometasone list epistaxis as the most common adverse event. The FDA-approved labeling for Flonase reports nosebleed incidence of 6% to 8% in clinical trials versus 3% to 4% with placebo [6].
• Hypertension. Elevated blood pressure does not directly cause nosebleeds, but it can prolong them. A 2020 meta-analysis in the European Archives of Oto-Rhino-Laryngology found a statistically significant association between hypertension and recurrent epistaxis (OR 1.61 to 95% CI 1.23, 2.10) [7].
• Inherited bleeding disorders. Hereditary hemorrhagic telangiectasia (HHT), also called Osler-Weber-Rendu syndrome, affects approximately 1 in 5,000 people and causes recurrent, often severe nosebleeds due to abnormal blood vessel formation in the nasal mucosa [8].
• Allergic rhinitis and infections. Inflammation from allergies or viral upper respiratory infections engorges nasal blood vessels and thins the overlying mucosa.
• Septal deviations and nasal trauma. A deviated septum exposes one side to more turbulent airflow, drying the mucosa unevenly.

When to See a Doctor: The Decision Framework

The majority of anterior nosebleeds resolve at home. A doctor visit becomes necessary in specific, well-defined scenarios. Do not wait if any of the following apply.

Seek emergency care if:

• Bleeding continues for more than 20 minutes despite firm, uninterrupted pinch pressure.
• Blood loss is heavy enough to cause lightheadedness, rapid heart rate, or pallor.
• The nosebleed follows a blow to the head or face with suspected fracture.
• You are taking warfarin, apixaban, rivaroxaban, or another anticoagulant and the bleed will not stop.
• Blood flows from both nostrils simultaneously or drains steadily down the back of the throat (suggesting a posterior source).

Schedule a non-urgent appointment if:

• Nosebleeds recur more than once per week over a span of several weeks.
• You notice easy bruising, bleeding gums, or heavy menstrual periods alongside nosebleeds (possible systemic clotting issue).
• A child has nosebleeds that interfere with sleep or school attendance.
• One-sided nasal obstruction accompanies recurrent bloody discharge (requires imaging to rule out a nasal mass).

Dr. John Palumbo, an otolaryngologist at Cleveland Clinic, has stated: "A single nosebleed that stops with pressure is almost never dangerous. What should prompt evaluation is the pattern: recurrent, bilateral, or accompanied by other bleeding symptoms that suggest an underlying disorder" [9].

How Nosebleeds Are Diagnosed

Diagnosis begins with a focused history and anterior rhinoscopy. The clinician will ask about frequency, duration, laterality, medications (especially anticoagulants), family history of bleeding disorders, and recent trauma or surgery [10].

Anterior rhinoscopy uses a nasal speculum and headlight to inspect Kiesselbach's plexus directly. In most cases, the bleeding source is visible as an eroded vessel or a clot on the anterior septum. The American Academy of Otolaryngology's 2020 clinical practice guideline on epistaxis recommends that clinicians "identify the bleeding site with anterior rhinoscopy before initiating any cauterization or packing intervention" [11].

If the anterior source is not identified, nasal endoscopy with a rigid or flexible scope examines deeper structures, including the posterior septum, lateral nasal wall, and nasopharynx. This is standard practice in posterior bleeds and in patients with unilateral obstruction.

Laboratory testing is not routine for a single anterior nosebleed. It becomes indicated when recurrent bleeding suggests a coagulopathy. A complete blood count (CBC), prothrombin time (PT), activated partial thromboplastin time (aPTT), and, in select cases, von Willebrand factor (vWF) antigen and activity levels help identify platelet disorders, factor deficiencies, or HHT [12]. Von Willebrand disease is the most common inherited bleeding disorder, affecting up to 1% of the general population, and recurrent epistaxis is often its presenting symptom in children [13].

Imaging (CT of the sinuses or MRI) is reserved for cases where endoscopy reveals a mass, when bleeding is refractory despite treatment, or when the clinical picture raises concern for a vascular malformation or neoplasm.

First Aid: How to Stop a Nosebleed at Home

Correct technique matters. Many people make the mistake of tilting the head backward, which directs blood down the pharynx and increases swallowing or aspiration risk.

The proper method, as outlined by the American Academy of Family Physicians (AAFP):

1. Sit upright and lean slightly forward.
2. Pinch the soft, fleshy part of the nose (not the bony bridge) between your thumb and index finger.
3. Maintain firm, continuous pressure for a full 15 minutes without checking.
4. Breathe through the mouth.
5. Apply a cold compress to the bridge of the nose if desired (evidence for this is limited, but it is not harmful) [14].

After 15 minutes, release pressure gently. If bleeding restarts, repeat for another 15 minutes. Two rounds of 15-minute pressure that fail to control bleeding meet the threshold for an emergency department visit.

An over-the-counter topical decongestant spray containing oxymetazoline (Afrin) can be sprayed into the bleeding nostril before applying pressure. Oxymetazoline causes local vasoconstriction and a 2013 randomized trial in Annals of Emergency Medicine showed that oxymetazoline combined with pressure was more effective than pressure alone in stopping anterior epistaxis within 10 minutes (65% vs. 35%, P<0.01) [15].

Medical and Procedural Treatments for Nosebleeds

When first aid is insufficient, treatment escalates through a predictable sequence depending on whether the bleed is anterior or posterior.

Chemical cautery with silver nitrate sticks is the most common office-based intervention for recurrent anterior nosebleeds. The clinician applies the silver nitrate to the visible bleeding vessel on Kiesselbach's plexus under direct vision. Only one side of the septum should be cauterized per session to avoid septal perforation risk [16]. Success rates for anterior cautery range from 80% to 90% for a single visible bleeding point.

Anterior nasal packing is used when the bleeding site cannot be identified or cautery is not feasible. Options include ribbon gauze impregnated with petroleum jelly, preformed nasal sponges (Merocel), or inflatable balloon catheters (Rapid Rhino). A 2012 Cochrane review found no clear superiority of one packing type over another, though inflatable devices were associated with less discomfort on insertion and removal [17]. Packing typically remains in place for 24 to 48 hours. All patients with nasal packing should receive antibiotics to prevent toxic shock syndrome, per current ENT practice guidelines [11].

Posterior packing or balloon tamponade is indicated for posterior bleeds refractory to anterior measures. A dual-balloon catheter (such as the Epistat) occludes both the posterior choana and the anterior nasal cavity. Patients with posterior packing require hospital admission for monitoring because of the risk of hypoxia, vagal stimulation, and aspiration [18].

Endoscopic sphenopalatine artery ligation (ESPAL) has become the preferred surgical option when packing fails. A 2015 systematic review in The Laryngoscope reported a success rate of 92% to 100% across 17 studies, with low complication rates [19]. Dr. Richard Douglas, professor of otolaryngology at the University of Auckland, has noted: "Endoscopic ligation has largely replaced posterior packing as definitive treatment because it addresses the arterial source directly with lower morbidity and shorter hospital stays" [20].

Embolization by interventional radiology is reserved for patients who are poor surgical candidates or in whom ligation has failed. Angiographic embolization of the internal maxillary artery achieves hemostasis in 88% to 97% of cases but carries a small risk of stroke or tissue necrosis [21].

Nosebleeds in Children: Special Considerations

Epistaxis is extremely common in the pediatric population. A UK-based population study published in the International Journal of Pediatric Otorhinolaryngology found that 30% of children under age 5 and 56% of children ages 6 to 10 had experienced at least one nosebleed in the prior year [22].

The overwhelming majority are anterior, self-limited, and benign. Digital trauma (nose picking) is the primary driver, followed by upper respiratory infections and allergic rhinitis. Parents should be taught the correct pinch technique and reassured that occasional nosebleeds in an otherwise healthy child rarely signal serious pathology.

Recurrent nosebleeds in children that occur more than once weekly, produce significant volume, or are accompanied by bruising warrant a CBC and coagulation screen. Von Willebrand disease, idiopathic thrombocytopenic purpura (ITP), and less commonly, hematologic malignancies should be considered in the differential [13].

Topical petroleum jelly (Vaseline) applied nightly to the anterior septum for 4 to 8 weeks has been shown to reduce recurrence in children. A 2019 randomized controlled trial in The BMJ involving 312 children with recurrent epistaxis found that antiseptic cream (Naseptin) was not superior to petroleum jelly for preventing recurrences at 6 months [23].

Preventing Nosebleeds: Evidence-Based Strategies

Prevention depends on the identified or suspected trigger.

• Humidify indoor air. Keeping room humidity between 40% and 50% during dry months protects the nasal mucosa. A bedside humidifier is especially useful during winter heating season.
• Apply nasal moisturizer. A thin layer of saline gel or petroleum jelly inside each nostril twice daily reduces mucosal cracking. Saline nasal sprays (0.9% NaCl) used 2 to 3 times daily keep the lining hydrated without medication side effects [24].
• Modify anticoagulant therapy only with physician guidance. Patients on warfarin with recurrent epistaxis should have their INR checked. An INR above the therapeutic range (typically 2.0 to 3.0 for most indications) significantly increases bleeding risk. Never stop an anticoagulant without consulting the prescribing physician.
• Correct nasal steroid spray technique. Aim the spray laterally (toward the ear on the same side), away from the septum. Spraying directly at the septum concentrates the drug on Kiesselbach's plexus and increases nosebleed risk [6].
• Manage allergic rhinitis. Treating underlying nasal inflammation with second-generation antihistamines or intranasal corticosteroids (used correctly) reduces the congestion-and-blowing cycle that damages blood vessels.
• Avoid nose picking. For children, keeping fingernails short and addressing underlying itch (from allergies or dryness) reduces the urge.

Nosebleeds and Blood Thinners: What Patients Should Know

Anticoagulant-associated epistaxis is a growing clinical concern as the population ages and prescribing rates for DOACs (direct oral anticoagulants) continue to rise. A 2021 analysis from the National Inpatient Sample found that epistaxis-related hospitalizations increased by 26% between 2009 and 2018, a trend paralleling the expansion of anticoagulant use [25].

For patients on warfarin, the first step when nosebleeds become recurrent is checking the INR. Supratherapeutic values above 3.0 require dose adjustment and possibly vitamin K administration. For patients on DOACs (apixaban, rivaroxaban, dabigatran, edoxaban), there is no routine monitoring equivalent to INR. If a patient on a DOAC presents with an uncontrolled nosebleed, specific reversal agents are available: idarucizumab for dabigatran and andexanet alfa for factor Xa inhibitors, though these are reserved for life-threatening or uncontrollable hemorrhage [26].

Antiplatelet agents such as aspirin and clopidogrel also contribute to epistaxis risk. A patient taking dual antiplatelet therapy (DAPT) after a coronary stent should not discontinue either agent without cardiology input, even in the setting of recurrent nosebleeds. The risk of stent thrombosis from premature DAPT cessation typically outweighs the risk from epistaxis [27].